ArticleESC heart failure2019

Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy.

Pieter Martens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.